# Trauma Acute Pain Treatment With Methoxyflurane Vaporized (PENTHROX®): Efficacy and Safety Study (MEDITA)

> **NCT03585374** · PHASE3 · COMPLETED · sponsor: **Mundipharma Pharmaceuticals srl** · enrollment: 272 (actual)

## Conditions studied

- Acute Traumatic Pain

## Interventions

- **COMBINATION_PRODUCT:** Methoxyflurane and Penthrox inhaler
- **DRUG:** Morphine
- **DRUG:** Paracetamol
- **DRUG:** Ketoprofen

## Key facts

- **NCT ID:** NCT03585374
- **Lead sponsor:** Mundipharma Pharmaceuticals srl
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-08
- **Primary completion:** 2019-02-08
- **Final completion:** 2019-02-22
- **Target enrollment:** 272 (ACTUAL)
- **Last updated:** 2019-05-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03585374

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03585374, "Trauma Acute Pain Treatment With Methoxyflurane Vaporized (PENTHROX®): Efficacy and Safety Study (MEDITA)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03585374. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*